Filing Flows › Medpace Holdings (MEDP) › Metabolic revenue
Medpace Holdings (MEDP) Metabolic revenue by quarter
Medpace Holdings' Metabolic revenue was $230M in Q3 2026 (third quarter 2026), +10% from Q2 2026. Over the last 7 quarters it ranged from $170M (Q1 2025) to $230M (Q3 2026).
| Quarter | Metabolic revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $230M | +10% | +19% |
| Q2 2026 | $209M | +4% | +11% |
| Q1 2026 | $201M | +3% | +18% |
| Q4 2025 | $196M | +2% | — |
| Q3 2025 | $193M | +2% | — |
| Q2 2025 | $189M | +11% | — |
| Q1 2025 | $170M | — | — |
Q3 2026 at a glance
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
Questions
What is Medpace Holdings' Metabolic revenue?
Medpace Holdings' Metabolic revenue was $230M in Q3 2026 (third quarter 2026), +10% from Q2 2026.
How has Medpace Holdings' Metabolic revenue changed?
Over the last 7 quarters it ranged from $170M (Q1 2025) to $230M (Q3 2026).